Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation. | J Clin Med | 2026 | 41753067 | PubTator, text mining | PubMed |
| Systematic Review of Non-Coding Genomic Variants in Globin and Non-Globin Clusters and Their Impact on Phenotypic Severity in Thalassemia and Sickle Cell Disease. | J Clin Med | 2026 | 41753033 | PubTator, text mining | PubMed |
| Special Issue "Genetic Modifiers of Hemoglobinopathies: Recent Advances and Future Directions". | Int J Mol Sci | 2026 | 41752026 | PubTator, text mining | PubMed |
| Fetal Hemoglobin Modulation in Sickle Cell Disease: βs Haplotypes, Key Polymorphisms Identified by GWAS, and Advances in γ-Globin Editing: An Updated Overview. | Genes (Basel) | 2026 | 41751519 | PubTator, text mining | PubMed |
| Complex HBB gene editing outcomes revealed by a fluorescent reporter cell model. | Mol Ther Nucleic Acids | 2026 | 41736887 | PubTator, text mining | PubMed |
| Synergistic Potential of Thalidomide and Hydroxyurea in Sickle Cell Disease Management: A Promising Combination Therapy. | Indian J Hematol Blood Transfus | 2026 | 41728140 | PubTator, text mining | PubMed |
| Placental iron utilisation in fetal growth restriction: alterations in mitochondrial haem synthesis and iron-sulphur cluster assembly pathways. | J Physiol | 2026 | 41697720 | PubTator, text mining | PubMed |
| miRNA-Mediated Regulation of γ-Globin to β-Globin Switching: Therapeutic Potential in β-Hemoglobinopathies. | Int J Mol Sci | 2026 | 41683631 | PubTator, text mining | PubMed |
| Functional correction and genome integrity with duplex base editing of β-thalassemic hematopoietic stem cells. | Genome Biol | 2026 | 41629994 | PubTator, text mining | PubMed |
| Examination of In Vivo Mutations in VP4 (VP8*) of the Rotarix® Vaccine from Shedding of Children Living in the Amazon Region. | Viruses | 2026 | 41600834 | PubTator, text mining | PubMed |
| DNA methylation matters: methylation of the γ-globin (HBG) gene promoters is required for postnatal silencing of HbF. | Blood | 2026 | 41587075 | PubTator, text mining | PubMed |
| BMP6 as a therapeutic target for preeclampsia: enhancing trophoblast invasion and vascular mimicry. | Cell Mol Life Sci | 2026 | 41577865 | PubTator, text mining | PubMed |
| Internalization and Localization of Murine Norovirus in Hydroponically Grown Green Onion (Allium Fistulosum L.). | Food Environ Virol | 2026 | 41575685 | PubTator, text mining | PubMed |
| Hemoglobin Chapel Hill masquerading as hemoglobin S in newborn sickle cell screening: A case study. | Clin Biochem | 2026 | 41558590 | PubTator, text mining | PubMed |
| Triple base editor catalyzes saturation mutation of adenine, cytidine, and guanine. | Nucleic Acids Res | 2026 | 41533583 | PubTator, text mining | PubMed |
| An optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing. | Blood | 2026 | 41525452 | PubTator, text mining | PubMed |
| Single-cell multiplex approaches deeply map ON-target CRISPR-genotoxicity and reveal its mitigation by palbociclib and long-term engraftment. | Nat Commun | 2026 | 41519897 | PubTator, text mining | PubMed |
| Structural insights into a broadly reactive nanobody that binds pathogenic and non-pathogenic lagoviruses. | J Virol | 2026 | 41504443 | PubTator, text mining | PubMed |
| Identification of RBM3 as a novel regulator of human fetal hemoglobin expression. | Int Immunopharmacol | 2026 | 41455370 | PubTator, text mining | PubMed |
| COUP-TFII regulates hemoglobin switching by activating the BCL11A-XL repressor LIN28B and directly binding δ and β globin promoters in fetal versus adult erythroid cells. | Haematologica | 2026 | 41307130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=3